GLOMERULAR DISEASE IN 2016: New advances in the treatment of glomerular disease

    loading  Checking for direct PDF access through Ovid

Abstract

Studies published in 2016 provide insights that bring us closer to achieving the goal of personalized therapy for primary glomerular diseases. Moreover, promising renal outcome data with new classes of glucose-lowering agents — SGLT2 inhibitors and GLP-1 agonists — offer new hope for patients with diabetic nephropathy.

Related Topics

    loading  Loading Related Articles